Jinyu Bio-Technology (600201.SH): The genetically engineered subunit vaccine for Clostridium perfringens Type A disease in cattle has obtained a new veterinary drug registration certificate.
Biological Co., Ltd. (600201.SH) issued an announcement, in accordance with the National "Regulations on Veterinary Drug Administration" and "Measures for Veterinary Drug Registration"...
Jinyu Bio-Technology (600201.SH) announces that, in accordance with the national regulations "Veterinary Drug Management Regulations" and "Veterinary Drug Registration Measures", the company's wholly-owned subsidiary, Jinyu Baoling Biopharmaceutical Co., Ltd. (hereinafter referred to as "Jinyu Baoling"), in collaboration with other companies, has been approved by the Ministry of Agriculture and Rural Affairs to develop a new veterinary drug, namely the genetically engineered subunit vaccine for Bovine Clostridial Disease (Type A). The "New Veterinary Drug Registration Certificate" has been issued for this product.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
